Xgeva

Denosumab

7.6 High risk

Xgeva & Osteonecrosis of jaw

16.9%

of users reported Osteonecrosis of jaw

86.1%

also reported Severe reaction

53.0%

are women

Most common medical consequences

Severe reaction
86.1%
Hospitalization
9.7%
Disability
3.2%
Death
0.8%
Life-threatening condition
0.1%
Medical Intervention
<0.1%

Have you experienced any negative side effects from this medication?

Xgeva: general information

Most common side effects (215)

Most commonly affected ages

10 - 19 years
0.8%
20 - 29 years
0.7%
30 - 39 years
2.3%
40 - 49 years
6.2%
50 - 59 years
16.2%
60 - 69 years
27.8%
70 - 79 years
29.6%
80 - 89 years
15.3%
90 - 99 years
1.2%
On this page
Xgeva & Osteonecrosis of jaw
Xgeva: general information